Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Up‐regulated deubiquitinase USP 4 plays an oncogenic role in melanoma

14 Mar 2018

Abstract excerpt

Melanoma is the most malignant skin cancer with increasing incidence worldwide. Although innovative therapies such as BRAF inhibitor and immune checkpoint inhibitor have gained remarkable advances, metastatic melanoma remains an incurable disease for its notorious aggressiveness. Therefore, further clarification of the underlying mechanism of melanoma pathogenesis is critical for the improvement of melanoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Ocular Oncology and Treatments
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29542252
DOI: 10.1111/jcmm.13603

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Up‐regulated deubiquitinase USP 4 plays an oncogenic role in melanomaPMID 29542252Read ↗

Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting TherapiesSemantic proximity Read ↗

Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma PathogenesisSemantic proximity Read ↗

Bimodal Regulation of the PRC2 Complex by USP7 Underlies MelanomagenesisSemantic proximity Read ↗

Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatmentSemantic proximity Read ↗

USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axisSemantic proximity Read ↗

Targeting deubiquitinase USP28 for cancer therapySemantic proximity Read ↗

PSMD14 drives melanoma cell survival and MAPK inhibitor resistance through histone H2A deubiquitinationSemantic proximity Read ↗

Selective USP7 Inhibition Synergizes with MEK1/2 Inhibitor to Enhance Immune Responses and Potentiate Anti-PD-1 Therapy in NRAS-Mutant Melanoma.Semantic proximity Read ↗

Role of Deubiquitinases in Human Cancers: Potential Targeted TherapySemantic proximity Read ↗

Hepatocyte growth factor promotes melanoma metastasis through ubiquitin-specific peptidase 22-mediated integrins upregulationSemantic proximity Read ↗

USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell CarcinomaSemantic proximity Read ↗

KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growthSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.